News & Updates
Filter by Specialty:
Which factors raise HCC risk in patients with cured HCV?
Predictors of hepatocellular carcinoma (HCC) differ in patients with virologically cured hepatitis C virus (HCV) infection with and without cirrhosis, according to a study. However, changes in fibrosis-4 (FIB-4) scores over time are associated with HCC risk in both cohorts.
Which factors raise HCC risk in patients with cured HCV?
24 Nov 2022
Coffee intake lowers risk of endometrial cancer
Women who love to drink coffee will have more reason to do so following a study that reports an association between coffee consumption and a reduced risk of endometrial cancer, particularly among those with higher body mass index (BMI).
Coffee intake lowers risk of endometrial cancer
23 Nov 2022
MDT without ADT delays systemic therapy initiation in recurrent prostate cancer
In patients with solitary metastatic recurrences of prostate cancer, metastasis-directed therapy (MDT without androgen deprivation therapy (ADT) can lead to delayed initiation of systemic therapy, according to a study.
MDT without ADT delays systemic therapy initiation in recurrent prostate cancer
21 Nov 2022
Laparoscopic better than abdominal radical hysterectomy for cervical cancer
Laparoscopic radical hysterectomy (LRH) leads to more positive outcomes than abdominal radical hysterectomy (ARH) in the treatment of cervical cancer, reveals a study.
Laparoscopic better than abdominal radical hysterectomy for cervical cancer
21 Nov 2022
CRT vs SBRT: Which approach yields better outcomes in PDAC?
Multiagent chemotherapy (MAC) followed by conventionally fractionated radiotherapy (CRT) shows rates of margin-negative resection (R0) and pathologic complete response similar to those of MAC plus stereotactic body radiotherapy (SBRT) in patients with localized pancreatic ductal adenocarcinoma (PDAC), according to a study. However, MAC plus CRT is associated with less regional lymphatic disease.
CRT vs SBRT: Which approach yields better outcomes in PDAC?
20 Nov 2022
Cell-cycle progression tied to metastasis-free survival in high-risk prostate cancer
Cell-cycle progression, but not phosphatase and tensin homolog, appears to significantly elevate the risk of metastasis in men with prostate cancer following Cancer of the Prostate Risk Assessment Post-Surgical adjustment, suggests a study.
Cell-cycle progression tied to metastasis-free survival in high-risk prostate cancer
17 Nov 2022
Could a single screening colonoscopy prevent CRC?
Results of the NordICC* trial from Europe, presented at the United European Gastroenterology Week (UEG 2022), have hinted at the benefit of a single screening colonoscopy in preventing colorectal cancer (CRC).
Could a single screening colonoscopy prevent CRC?
16 Nov 2022
Depressive symptoms implicated in lung cancer via smoking habits
Individuals with greater depressive symptoms are at risk of developing lung cancer, with the association directly and indirectly attributed to smoking habits, as reported in a study.